CIK 0001819253
- Accelerated filer
- Smaller reporting company
- Emerging growth company
biote Corp.
Sign in to watch- Ticker
- BTMD
- Exchange
- Nasdaq
- Industry
- Medicinal Chemicals & Botanical Products
- FY end
- Dec 31
- Entity type
- Operating
- EIN
- 851791125
- Phone
- +1 972-486-9346
- Business address
- 1875 W. WALNUT HILL LN #100, IRVING, TX, 75038
- Former names
- Haymaker Acquisition Corp. III
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2026-05-12 | Cone Stephen Mark Director | Grant or award · Deferred Settlement RSU | +31,481 | 69,822 | ||
| 2026-05-12 | Cone Stephen Mark Director | Grant or award · Stock Option (Right to Buy) | +130,000 | 130,000 | ||
| 2025-05-13 | Cone Stephen Mark Director | Grant or award · Deferred Settlement RSU | +17,989 | 38,341 | ||
| 2025-05-13 | Cone Stephen Mark Director | Grant or award · Stock Option (Right to Buy) | +104,547 | 104,547 | ||
| 2025-03-17 | Cone Stephen Mark Director | Purchase | +38,104 | $3.88 | $148K | 160,829 |
| 2024-05-21 | Cone Stephen Mark Director | Grant or award · Deferred Settlement RSU | +10,828 | 20,352 | ||
| 2024-05-21 | Cone Stephen Mark Director | Grant or award · Stock Option (Right to Buy) | +65,258 | 143,763 | ||
| 2023-06-30 | Cone Stephen Mark Director | Exercise or conversion | +6,058 | 122,725 | ||
| 2023-06-30 | Cone Stephen Mark Director | Exercise or conversion · Phantom Stock | −6,058 | 0 | ||
| 2023-05-17 | Cone Stephen Mark Director | Grant or award · Deferred Settlement RSU | +9,524 | 9,524 | ||
| 2023-05-17 | Cone Stephen Mark Director | Grant or award · Stock Option (Right to Buy) | +46,809 | 78,505 | ||
| 2023-03-31 | Cone Stephen Mark Director | Exercise or conversion | +9,844 | 116,667 | ||
| 2023-03-31 | Cone Stephen Mark Director | Exercise or conversion · Phantom Stock | −9,844 | 6,058 | ||
| 2023-01-09 | Cone Stephen Mark Director | Purchase | +83,350 | $3.00 | $250K | 106,823 |
| 2022-12-31 | Cone Stephen Mark Director | Exercise or conversion | +9,844 | 23,473 | ||
| 2022-12-31 | Cone Stephen Mark Director | Exercise or conversion · Phantom Stock | −9,844 | 15,902 | ||
| 2022-11-15 | Cone Stephen Mark Director | Grant or award · Stock Option (Right to Buy) | +31,696 | 31,696 | ||
| 2022-11-15 | Cone Stephen Mark Director | Grant or award · Stock Option (Right to Buy) | +31,696 | 31,696 | ||
| 2022-09-30 | Cone Stephen Mark Director | Exercise or conversion | +13,629 | 13,629 | ||
| 2022-09-30 | Cone Stephen Mark Director | Exercise or conversion · Phantom Stock | −13,629 | 25,746 |
Page 1 of 2 · 21 trades